QNRX ▼ -0.8% - Quoin Pharmaceuticals, Ltd. $QNRX - CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome Quoin Pharmaceuticals' stock declined 0.8% after the company announced that the FDA granted Rare Pediatric Disease Designation for its QRX003 candidate in peeling skin syndrome. The designation, while potentially valuable for development incentives and priority review, may have disappointed investors expecting a broader clinical or regulatory milestone for the program. 08-SEP-2026 02:12 PM ET